VEGF receptor expression and signaling in human bladder tumors

被引:0
|
作者
Weicheng Wu
Xiaodong Shu
Harut Hovsepyan
Raymond D Mosteller
Daniel Broek
机构
[1] Norris Comprehensive Cancer Center,Department of Biochemistry and Molecular Biology
[2] Keck School of Medicine at the University of Southern California,undefined
来源
Oncogene | 2003年 / 22卷
关键词
VEGF; sphingosine kinase; bladder tumor;
D O I
暂无
中图分类号
学科分类号
摘要
Overexpression of vascular endothelial growth factor receptors (VEGFRs) has been reported in a variety of tumor types. Here we find that 11 out of the 14 bladder tumor cell lines examined express one or more VEGF receptors. Analysis of the T24 bladder tumor cell line reveals a functional autocrine loop involving VEGF and the Flk-1 receptor. Blocking VEGF expression in T24 cells results in a decrease in DNA synthesis. The Flk-1 receptor in T24 cells is phosphorylated in response to VEGF-121 or VEGF-165, and an Flk-1 inhibitor blocks VEGF to ERK signaling. We report that VEGF stimulation of T24 cells results in activation of H- and N-Ras and this is dependent on cellular sphingosine kinase 1 (SPK1) activity. Previously, we found VEGF-induced activation of Ras appears to be independent of a Ras-guanine nucleotide exchange factors (GEFs). Here we report that sphingosine can stimulate Ras-GTPase activating protein (GAP) activity in vitro, and sphingosine-1-phosphate (SPP) can block the stimulatory effects of sphingosine. We present a model where the balance between sphingosine and SPP regulates Ras-GAP activity such that stimulation of SPK1 favors downregulation of Ras-GAP and thereby the activation of Ras proteins. These data highlight a VEGF pathway that may be involved in the survival and proliferation of bladder tumor cells as well as other tumor cell types.
引用
收藏
页码:3361 / 3370
页数:9
相关论文
共 50 条
  • [1] VEGF receptor expression and signaling in human bladder tumors
    Wu, WC
    Shu, XD
    Hovsepyan, H
    Mosteller, RD
    Broek, D
    ONCOGENE, 2003, 22 (22) : 3361 - 3370
  • [2] Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling
    Drewlo, S.
    Levytska, K.
    Sobel, M.
    Baczyk, D.
    Lye, S. J.
    Kingdom, J. C. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) : 2486 - 2497
  • [3] Hypoxia and VEGF mRNA expression in human tumors
    Ziemer, LS
    Koch, CJ
    Maity, A
    Magarelli, DP
    Horan, AM
    Evans, SM
    NEOPLASIA, 2001, 3 (06): : 500 - 508
  • [4] VEGF and VEGF receptor expression in human chronic critical limb ischaemia
    Choksy, S
    Pockley, AG
    Wajeh, YE
    Chan, P
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2004, 28 (06) : 660 - 669
  • [5] RETINOIC ACID RECEPTOR IN HUMAN BLADDER-TUMORS
    FAGG, SL
    HUGHES, A
    FIELDING, JWL
    DAWSONEDWARDS, P
    HUGHES, MA
    HOWIE, A
    CLINICAL ONCOLOGY, 1982, 8 (04): : 329 - 334
  • [6] THE PRESENCE OF RETINOIC ACID RECEPTOR IN HUMAN BLADDER-TUMORS
    FAGG, SL
    HUGHES, A
    DAWSONEDWARDS, P
    HUGHES, MA
    BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 309 - 309
  • [7] THE PRESENCE OF RETINOIC ACID RECEPTOR IN HUMAN BLADDER-TUMORS
    FAGG, SL
    HUGHES, A
    WILSON, A
    DAWSONEDWARDS, P
    HUGHES, MA
    BRITISH JOURNAL OF SURGERY, 1981, 68 (11) : 805 - 806
  • [8] Analysis of erythropoietin receptor expression in human tumors
    Sinclair, A. M.
    Busse, L.
    Rogers, N.
    Kassner, P.
    Watson, V.
    Arnold, G.
    Archibeque, I.
    Van, G.
    Sarosi, I.
    Elliott, S.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 104 - 104
  • [9] Somatostatin receptor subtype expression in human tumors
    Hofland, LJ
    Lamberts, SWJ
    ANNALS OF ONCOLOGY, 2001, 12 : S31 - S36
  • [10] The expression of VEGF and VEGF-1 mRNA in neovasculature in human brain tumors and rat transplanted brain tumors.
    Sawada, T
    Kato, Y
    Takekawa, Y
    Kobayashi, M
    BRAIN PATHOLOGY, 2000, 10 (04) : 734 - 735